Palvella Therapeutics PVLA
NASDAQ PVLA
$135.10 -2.83 (-2.05%)
As of: Oct 1, 2026 · 12:59 PM EDT

Palvella Therapeutics (PVLA) Other financing activities (2013 - 2026)

Updated

Palvella Therapeutics (PVLA) reported Other financing activities of $14.25 million for Q1 2026.

Analysis

Palvella Therapeutics (PVLA) Other financing activities (2013 - 2026) Analysis & Trends

For FY2014, Palvella Therapeutics posted Other financing activities of $474.00.

  • By year, Other financing activities came in at $1,800 in FY2013.
  • The Q1 2026 figure ranks as the lowest quarterly Other financing activities since Q1 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Palvella Therapeutics 1.99 Bn 1.73 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 14.25 Mn
Sep 30, 2014 3,000.00
Mar 31, 2014 400.00
Dec 31, 2013 1,600.00
API Access

Palvella Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=PVLA&period=max&api_key=YOUR_API_KEY